Advancing CAIX-Targeted Radiopharmaceuticals: Developing Next-Generation Precision Diagnostics for Clear Cell Renal Cell Carcinoma
2:30 pm - Thursday 3rd December 2026
- Evaluating the clinical rationale for targeting CAIX to improve the detection and characterisation of clear cell renal cell carcinoma
- Optimising small molecule radiopharmaceutical design to enable same-day imaging and improved detection of primary and metastatic disease
- Generating early clinical evidence through investigator-initiated studies to validate target engagement, imaging performance and clinical translation